Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5000 participants
OBSERVATIONAL
2018-01-01
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants
NCT00904774
Multiparametric Bronchopulmonary Prediction
NCT04785859
Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
NCT05055193
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
NCT04756297
Clinic Features and Outcome of BPD (SGBPD)
NCT04237844
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bronchopulmonary dysplasia group
infants diagnosed with bronchopulmonary dysplasia
occurrence of bronchopulmonary dysplasia
We observe the incidence of bronchopulmonary dysplasia
no bronchopulmonary dysplasia
infants not diagnosed with bronchopulmonary dysplasia
occurrence of bronchopulmonary dysplasia
We observe the incidence of bronchopulmonary dysplasia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
occurrence of bronchopulmonary dysplasia
We observe the incidence of bronchopulmonary dysplasia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with gestational age \<36 weeks
* admitted to the NICU within 24 h after birth
* the length of stay was more than 1 week
Exclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kai Mu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kai Mu
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MU Kai, Doctor
Role: STUDY_DIRECTOR
Qianfoshan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qianfoshan Hospital
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QFS-2018-1201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.